Our over-reliance on antibiotics to find relief from numerous ailments, including cold and flu symptoms, is a major health concern – according to the Centers for Disease Control and Prevention.
So, what are “superbugs?” Well they are defined as “strains of bacteria that are resistant to the majority of antibiotics commonly used today”. These drug-resistant bacteria can cause serious skin and urinary tract infections, as well as pneumonia, tuberculosis, and even sepsis.
While bacteria’s ability to adapt to drugs is a natural part of its evolution, our misuse of antibiotics is speeding up the process.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).